Clinical trial

A Longitudinal Observational Study of Self-reported Cardiomyopathy in the Heart Hive

Name
18IC4954
Description
This is an online registry and database of patients with cardiomyopathy and myocarditis, coupled with an observational study of DCM and HCM.
Trial arms
Trial start
2019-11-09
Estimated PCD
2024-11-09
Trial end
2024-11-09
Status
Recruiting
Treatment
Research genetic analysis
Genetic analysis of DNA extracted from saliva. Participants can opt in to receive individual results of research genetic analysis for a predefined panel of clinically actionable cardiomyopathy genes.
Size
10000
Primary endpoint
Number of participants with cardiovascular cause of death
90 years
Number of participants with arrhythmic events
90 years
Number of participants with major heart failure events
90 years
Eligibility criteria
Inclusion Criteria: * Adult (age 18 and over), * Males and Females, * Capacity to provide informed consent, * Patients with a confirmed diagnosis of cardiomyopathy or myocarditis, * People with a family history of cardiomyopathy confirmed in a first or second degree relative. Note: Pregnant women are eligible. This study is observational and entirely separate from clinical care. Exclusion criteria: * Patients who lack capacity to consent for themselves, * Vulnerable groups (e.g. those under 18, prisoners, those in a dependent relationship, the mentally ill). * Patients with a confirmed history of coronary artery disease: * who have been informed by their treating physician that their cardiomyopathy is secondary to their coronary artery disease, or * who have undergone previous percutaneous coronary intervention or coronary bypass surgery * History of primary valvular heart disease or congenital heart disease * Severe, untreated or untreatable hypertension (systolic blood pressures routinely \>180 mm Hg and/or diastolic blood pressures \>120 mm Hg)
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': True, 'targetDuration': '50 Years', 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'bioSpec': {'retention': 'SAMPLES_WITH_DNA', 'description': 'Saliva'}, 'enrollmentInfo': {'count': 10000, 'type': 'ESTIMATED'}}
Updated at
2024-03-06

1 organization

1 product

2 indications

Indication
Cardiomyopathy
Indication
Myocarditis